Paysign, Inc. (PAYS)

NASDAQ: PAYS · Real-Time Price · USD
6.22
+0.13 (2.13%)
At close: Apr 24, 2026, 4:00 PM EDT
6.30
+0.08 (1.29%)
After-hours: Apr 24, 2026, 7:13 PM EDT
Market Cap343.25M +208.4%
Revenue (ttm)82.03M +40.5%
Net Income7.55M +97.9%
EPS0.13 +85.7%
Shares Out 55.19M
PE Ratio47.85
Forward PE26.19
Dividendn/a
Ex-Dividend Daten/a
Volume388,275
Open6.10
Previous Close6.09
Day's Range5.90 - 6.22
52-Week Range2.19 - 8.88
Beta0.64
AnalystsStrong Buy
Price Target9.42 (+51.45%)
Earnings DateMay 12, 2026

About PAYS

Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. The company offers solutions for corporate rewards, prepaid gift cards, general-purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card and software s... [Read more]

Sector Technology
IPO Date Apr 2, 1998
Employees 226
Stock Exchange NASDAQ
Ticker Symbol PAYS
Full Company Profile

Financial Performance

In 2025, Paysign's revenue was $82.03 million, an increase of 40.50% compared to the previous year's $58.38 million. Earnings were $7.55 million, an increase of 97.90%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for PAYS stock is "Strong Buy." The 12-month stock price target is $9.42, which is an increase of 51.45% from the latest price.

Price Target
$9.42
(51.45% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Paysign to Host First Quarter 2026 Earnings Call

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host First Quarter 2026 Earnings Call.

10 days ago - Business Wire

Paysign Earnings Call Transcript: Q4 2025

Revenue grew 40.5% to $82M in 2025, with net income up 98% and strong margin expansion. Patient Affordability revenue surged 168%, and 2026 guidance calls for 30–35% growth, driven by both plasma and pharma segments.

4 weeks ago - Transcripts

Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results; Patient Affordability Drives 40% Revenue Growth and Significant Margin Expansion

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results.

4 weeks ago - Business Wire

Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Fourth Quarter and Full Year 2025 Earnings Call.

2 months ago - Business Wire

Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer 11th Annual Emerging Growth Conference.

3 months ago - Business Wire

Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Announces 2025 Performance Analysis of Patient Affordability Solutions.

3 months ago - Business Wire

Paysign Transcript: 17th Annual Southwest IDEAS Conference

Leadership with deep payments and banking expertise drives growth in patient affordability and plasma payment sectors. Proprietary technology and high client retention fuel strong financial performance, with revenue and margins rising year-over-year.

5 months ago - Transcripts

Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the 17th Annual Southwest IDEAS Investor Conference.

5 months ago - Business Wire

Paysign Earnings Call Transcript: Q3 2025

Q3 2025 saw record revenue and profit growth, led by a 142% surge in patient affordability revenue and continued expansion in plasma. Guidance for 2025 was raised, with strong margin improvements and robust cash flow, despite plasma industry oversupply and regulatory delays for new tech platforms.

5 months ago - Transcripts

Paysign, Inc. Reports Third Quarter 2025 Financial Results

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Third Quarter 2025 Financial Results.

5 months ago - Business Wire

Paysign to Host Third Quarter 2025 Earnings Call

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2025 Earnings Call.

6 months ago - Business Wire

Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Appoints Jose Garcia as Executive Vice President, Life Science Solutions.

7 months ago - Business Wire

Paysign, Inc. Announces Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions

HENDERSON, Nev.--(BUSINESS WIRE)--Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Actions.

7 months ago - Business Wire

Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Opens 30,000 Square Foot Patient Service Support Center to Meet Growing Demand in Patient Affordability Business.

7 months ago - Business Wire

Paysign, Inc. to Present at the Lake Street Best Ideas Growth BIG9 Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Lake Street Best Ideas Growth BIG9 Conference.

8 months ago - Business Wire

Paysign, Inc. Announces Election of Dan Henry as Chairman of the Board

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Announces Election of Dan Henry as Chairman of the Board.

9 months ago - Business Wire

Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference.

9 months ago - Business Wire

Paysign Earnings Call Transcript: Q2 2025

Record Q2 revenue rose 33% to $19.1M, driven by 190% growth in patient affordability, while plasma revenue declined 4.7% year-over-year but rebounded sequentially. 2025 guidance was raised, with strong margin expansion and robust program pipeline supporting continued growth.

9 months ago - Transcripts

Paysign, Inc. Reports Second Quarter 2025 Financial Results

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Second Quarter 2025 Financial Results.

9 months ago - Business Wire

Paysign to Host Second Quarter 2025 Earnings Call

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Second Quarter 2025 Earnings Call.

10 months ago - Business Wire

Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign Accelerates Growth with Ahead-of-Schedule Transition of 123 Plasma Donation Centers.

11 months ago - Business Wire

Paysign, Inc. Awarded 132 Plasma Centers for Immediate Transition

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Awarded 132 Plasma Centers for Immediate Transition.

11 months ago - Business Wire

Paysign Transcript: The MicroCap Rodeo Conference - NYC

Paysign highlighted strong revenue growth, especially in patient affordability, and improved margins driven by technology and strategic acquisitions. Plasma business faces short-term headwinds, but investments and new software are expected to drive future growth.

11 months ago - Transcripts

Paysign, Inc. to Present at the MicroCap Rodeo Spring Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the MicroCap Rodeo Spring Conference.

11 months ago - Business Wire

PaySign Analysts Increase Their Forecasts After Better-Than-Expected Earnings

Paysign, Inc. posted stronger-than-expected earnings for the first quarter on Thursday.

1 year ago - Benzinga